Home > Insider Trading > Filing (0001209191-11-051764)

Filing Details

Accession Number:: 0001209191-11-051764
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-14 14:45:00
Reporting Period:: 2011-10-12

Filing Date:: 2011-10-14
Accepted Time:: 2011-10-14 14:45:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1207074	Virtusa Corp	VRTU	Services-Computer Programming Services (7371)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406397	A Kris Canekeratne	C/O Virtusa Corporation 2000 West Park Drive Westborough MA 01581	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-10-12	6,000	$15.68	1,363,029	No	4	S	Direct
Common Stock	Disposition	2011-10-13	4,000	$15.55	1,359,029	No	4	S	Direct
Common Stock	Disposition	2011-10-14	2,000	$15.54	1,357,029	No	4	S	Direct
Common Stock	Disposition	2011-10-12	3,000	$15.68	416,389	No	4	S	Indirect	Held by spouse
Conmon Stock	Disposition	2011-10-13	2,000	$15.55	414,389	No	4	S	Indirect	Held by spouse
Common Stock	Disposition	2011-10-14	1,000	$15.54	413,389	No	4	S	Indirect	Held by spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Held by spouse
No	4	S	Indirect	Held by spouse
No	4	S	Indirect	Held by spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	60,982	Indirect	Held by Kris Canekeratne Irreovocable Trust
Common Stock	60,982	Indirect	Held by Irrevocable Trust of spouse

Footnotes

These shares were sold pursuant to a 10b5-1 Sales Plan Agreement dated as of March 1, 2011 entered into by and between Kris Canekeratne and an investment bank.
This transaction was executed in multiple trades at prices ranging from $15.50 to $15.91 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 25,000 shares of performance based restricted stock granted under the Company's stock option plan on 11/3/08, which vest only upon the Company's achievement of certain revenue and operating income targets for each fiscal year over the next two fiscal years, commencing with the fiscal year ending 3/31/12. The performance based restricted shares vest at a rate of 25% per performance period upon achievement of applicable revenue and operating income targets for such fiscal year, with each fiscal year being a performance period. Also includes 12,500 shares of restricted stock granted in 5/17/10 that were accelerated and vested based on revenue achievement of the Company for the fiscal year ending 3/31/11. Also includes 8,758 shares of performance based restricted stock granted on 5/16/11, which vest only upon the Company's achievement of certain revenue targets for the fiscal year ending 3/31/12. The grantee retains voting rights in these shares until forfeited.
This transaction was executed in multiple trades at prices ranging from $15.36 to $15.80 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $15.33 to $15.80 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares were sold pursuant to a 10b5-1 Sales Plan Agreement dated as of March 1, 2011 entered into by and between Tushara Canekeratne and an investment bank.